Octahydroaminoacridine succinate

琥珀八氢氨吖啶

Report date: 2024/08/29 13:36:49
NME

Base Information

Drug NameOctahydroaminoacridine succinate
Drug Alias NameOctohydroaminoacridine succinate神尔洋华洋-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionButyrylcholinesterase inhibitorsAcetylcholinesterase inhibitors
TargetsAcetylcholinesteraseButyrylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesJiangsu Sheneryang High-Tech Co LtdChangchun Huayang High-Tech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTonghua Golden-Horse Pharmaceutical Industey Co LtdChangchun Huayang High-Tech Co LtdJiangsu Sheneryang High-Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A